LON:BELL Belluscura (BELL) Share Price, News & Analysis GBX 9.60 +0.35 (+3.78%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitors About Belluscura Stock (LON:BELL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Belluscura alerts:Sign Up Key Stats Today's Range 8.78▼ 1050-Day Range 9.28▼ 12.8552-Week Range 7▼ 27Volume210,058 shsAverage Volume264,250 shsMarket Capitalization£16.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBelluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.Read More… Receive BELL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Belluscura and its competitors with MarketBeat's FREE daily newsletter. Email Address BELL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com BELL Stock Analysis - Frequently Asked Questions How have BELL shares performed this year? Belluscura's stock was trading at GBX 23 at the beginning of the year. Since then, BELL shares have decreased by 58.3% and is now trading at GBX 9.60. View the best growth stocks for 2024 here. How do I buy shares of Belluscura? Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:BELL CUSIPN/A CIKN/A Webwww.belluscura.com PhoneN/AFaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.10) Trailing P/E RatioN/A Forward P/E Ratio12.68 P/E GrowthN/ANet Income£-18,600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-85.01% Return on Assets-43.53% Debt Debt-to-Equity Ratio1.16 Current Ratio3.25 Quick Ratio5.13 Sales & Book Value Annual Sales£1.80 million Price / Sales8.98 Cash FlowGBX 1.20 per share Price / Cash Flow8.00 Book ValueGBX 12 per share Price / Book0.80Miscellaneous Outstanding Shares168,410,000Free FloatN/AMarket Cap£16.17 million OptionableNot Optionable Beta1.05 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (LON:BELL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belluscura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.